UNITED THERAPEUTICS CORP.
Financial
Business Segments
| Segments | 2025 ($ Millions) |
|---|---|
| Tyvaso DPI | *** |
| Nebulized Tyvaso | *** |
| Remodulin | *** |
| Orenitram | *** |
| Unituxin | *** |
| Adcirca | *** |
| Other | *** |
Business Segments Chart
Business Regions
| Regions | 2025 ($ Millions) |
|---|---|
| U.S. | *** |
| Rest of World | *** |
Business Regions Chart
This information is available for BCC Research members only.